We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases

    Background

    Drug-induced interstitial lung disease (DILD) is a lung injury caused by various types of drugs and is a serious problem in both clinical...

    Yuchen Sun, Kosuke Saito, ... Masayuki Hanaoka in Respiratory Research
    Article Open access 14 January 2024
  2. Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database

    Background

    Drug-induced interstitial lung disease (DIILD) is a severe adverse event leading to morbidity and mortality. This study evaluated the...

    Keita Oura, Mizuki Tanaka, ... Mitsuhiro Nakamura in BMC Complementary Medicine and Therapies
    Article Open access 14 March 2024
  3. Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature

    Background

    Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has demonstrated effectiveness in treating ovarian, breast, and other cancers,...

    Hiroshi Ishimoto, Noriho Sakamoto, ... Hiroshi Mukae in BMC Pulmonary Medicine
    Article Open access 08 August 2023
  4. Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease

    Drug-induced interstitial lung disease (DILD) is the most common pulmonary adverse event of anticancer drugs. In recent years, the incidence of...

    Hua-** Dai, Fei Ma, ... Yi-qun Li in Current Medical Science
    Article Open access 01 February 2023
  5. Advances in multimodal imaging of lung injury

    Lung injury is caused by various physical and chemical damages that lead to the destruction of the structural integrity or dysfunction of the lungs,...

    Qian Zhou, Ziwei Zhang, ... Li Fan in Chinese Journal of Academic Radiology
    Article 27 June 2024
  6. Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway

    Background

    Pulmonary metabolic dysfunction can cause lung tissue injury. There is still no ideal drug to protect against...

    Chongyang Dai, Xue Lin, ... **aoyan Pu in BMC Pulmonary Medicine
    Article Open access 02 January 2024
  7. Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT

    Purpose

    To differentiate among infectious diseases, drug-induced lung injury (DILI) and pulmonary infiltration due to underlying malignancy (PIUM)...

    Nobuyuki Tanaka, Yoshie Kunihiro, ... Tsuneo Matsumoto in Japanese Journal of Radiology
    Article Open access 09 September 2022
  8. Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury

    Objectives

    To identify magnetic resonance imaging (MRI) features associated with injury type, severity, and liver transplantation (LT)/liver-related...

    Ting Wu, Dawei Yang, ... Hong Ma in European Radiology
    Article 18 August 2022
  9. Drug-induced interstitial lung disease due to over-the-counter cold medicine taken daily for 25 years: a case report

    Introduction

    We report a rare case of drug-induced interstitial lung disease due to over-the-counter cold medicine taken daily for 25 years to clear...

    Masataka Matsumoto, Isao Ito, Seizo Kadowaki in Journal of Medical Case Reports
    Article Open access 27 February 2023
  10. High-intensity intermittent training ameliorates methotrexate-induced acute lung injury

    Inflammation and oxidative stress are recognized as two primary causes of lung damage induced by methotrexate, a drug used in the treatment of cancer...

    Mohammad Amin Rajizadeh, Mahdiyeh Haj Hosseini, ... Mohammad-Abbas Bejeshk in BMC Pulmonary Medicine
    Article Open access 20 January 2024
  11. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study

    Background

    The objective of this research was to create and validate an interpretable prediction model for drug-induced liver injury (DILI) during...

    Yue **ao, Yanfei Chen, ... Tianchi Yang in BMC Medical Research Methodology
    Article Open access 20 April 2024
  12. Cyasterone ameliorates sepsis-related acute lung injury via AKT (Ser473)/GSK3β (Ser9)/Nrf2 pathway

    Background

    Acute lung injury (ALI) is a severe disease that can lead to acute respiratory distress syndrome (ARDS), characterized by intractable...

    Miao Lin, Weixi **e, ... Wei Liu in Chinese Medicine
    Article Open access 19 October 2023
  13. Protective Effects of Danmu Extract Syrup on Acute Lung Injury Induced by Lipopolysaccharide in Mice through Endothelial Barrier Repair

    Objective

    To investigate the effects of Danmu Extract Syrup (DMS) on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice and explore the...

    Han Xu, Si-cong Xu, ... Yong-hui Li in Chinese Journal of Integrative Medicine
    Article 21 November 2023
  14. Angiotensin Receptor Blockers and the Risk of Suspected Drug-Induced Liver Injury: A Retrospective Cohort Study Using Electronic Health Record-Based Common Data Model in South Korea

    Introduction

    Angiotensin receptor blockers are widely used antihypertensive drugs in South Korea. In 2021, the Korea Ministry of Food and Drug Safety...

    Hyunjoo Kim, Nayeong Son, ... Eunkyung Euni Lee in Drug Safety
    Article Open access 21 March 2024
  15. Blocking RAGE expression after injury reduces inflammation in mouse model of acute lung injury

    Background

    Receptor for Advanced Glycated Endproducts (RAGE) plays a major role in the inflammatory response to infectious and toxin induced acute...

    Lynne L. Johnson, Yared Tekabe, ... Jeanine D’Armiento in Respiratory Research
    Article Open access 20 January 2023
  16. Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury

    Background

    Radiation-induced lung injury (RILI) is the most common and serious complication of chest radiotherapy. However, reported radioprotective...

    **nrui Rao, Dong Zhou, ... Rui Zhou in Respiratory Research
    Article Open access 24 January 2023
  17. The efficacy of extracellular vesicles for acute lung injury in preclinical animal models: a meta-analysis

    Background

    With the increasing research on extracellular vesicles (EVs), EVs have received widespread attention as biodiagnostic markers and...

    Xuefeng Zhang, Zongyong Cheng, ... Zhihui He in BMC Pulmonary Medicine
    Article Open access 13 March 2024
  18. Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats

    Background

    Diabetes mellitus (DM) can aggravate lung ischemia-reperfusion (I/R) injury and is a significant risk factor for recipient mortality after...

    Tianhua Liu, Hong Wei, ... Wenzhi Li in BMC Pulmonary Medicine
    Article Open access 14 May 2024
  19. Inhibition of fatty acid synthase protects obese mice from acute lung injury via ameliorating lung endothelial dysfunction

    Background

    Obesity has been identified as a risk factor for acute lung injury/acute respiratory distress syndrome (ALI/ARDS). However, the underlying...

    Zhuhua Wu, Li Zhu, ... Yong Qi in Respiratory Research
    Article Open access 15 March 2023
  20. Bosutinib-induced lung injury: a report of two cases and literature review

    The prognosis of patients with chronic myeloid leukemia (CML) has improved dramatically since the development of tyrosine kinase inhibitors (TKIs)....

    Naoki Watanabe, Tomoiku Takaku, ... Miki Ando in International Journal of Hematology
    Article 28 February 2022
Did you find what you were looking for? Share feedback.